Skip to content
The Policy VaultThe Policy Vault

leniolisib phosphate — Blue Cross Blue Shield of Oklahoma

other FDA-labeled or compendia-supported indications for Ohio residents with Fully Insured or HIM Shop (SG) plans

Initial criteria

  • The member resides in Ohio
  • The plan is Fully Insured or HIM Shop (SG)
  • The patient does NOT have any FDA labeled contraindications to the requested agent
  • ONE of the following: (1) The patient has another FDA labeled indication for the requested agent and route of administration OR (2) The patient has another indication that is supported in compendia for the requested agent and route of administration OR (3) The prescriber has submitted TWO articles from major peer-reviewed professional medical journals (e.g., JAMA, NEJM, Lancet) supporting the proposed use(s) as generally safe and effective

Approval duration

12 months